Top brokers name 3 ASX shares to sell next week

Brokers aren't feeling overly positive on these shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that investors might want to hear about are summarised below. Here's why top brokers think investors ought to sell these shares next week:

Keyboard button with the word sell on it, symbolising the time being right to sell ASX stocks.

Image source: Getty Images

A2 Milk Company Ltd (ASX: A2M)

According to a note out of Citi, its analysts have downgraded this struggling infant formula company's shares to a sell rating and slashed their price target on them to $4.80. Citi has a number of concerns which it appears to believe have shifted the risks to the downside. These include supply disruption in China following lockdowns, weak pricing on Chinese ecommerce reseller platforms, and delays with its SAMR re-registration. Citi notes that the latter is far from guaranteed and could materially impact its sales should it not be granted. The A2 Milk share price is trading at $5.04 on Sunday.

IGO Ltd (ASX: IGO)

A note out of UBS reveals that its analysts have initiated coverage on this battery materials miner's shares with a sell rating and $12.65 price target. Although UBS notes that IGO provides investors with exposure to an attractive area of the resources sector, it isn't enough for a more positive rating. This is due to concerns over its current valuation. In addition, UBS fears that current lithium and nickel prices are unsustainable. The IGO share price was fetching $13.68 at Friday's close.

Magellan Financial Group Ltd (ASX: MFG)

Analysts at Macquarie have retained their underperform rating but lifted their price target on this fund manager's shares to $13.25. This follows the release of Magellan's latest funds under management update. While Macquarie was pleased to see Magellan's fund outflows slow, it thinks it may be too soon to get excited. The broker isn't expecting the outflows to stop any time soon. Particularly given the poor investment performance of its funds. The Magellan share price ended the week at $16.95.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk and Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Broker reiterates buy ratings on 2 ASX shares

These ASX shares remain worth watching.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

After more than quadrupling investors' money in a year, are PLS shares still a buy?

A leading analyst delivers his outlook for the soaring PLS share price.

Read more »

A young man wearing a bright yellow jumper and glasses purses his lips together and moves them to the side of his face as he wonders about something.
Broker Notes

Buy, hold, or sell? Life360, Iress, Lynas Rare Earths shares

Experts reveal their views.

Read more »

Worried woman calculating domestic bills.
Broker Notes

Why did this broker just lower its outlook on this ASX 200 stock?

Despite a lowered outlook, attractive upside remains.

Read more »